Drug Profile
Research programme: polymixin derivatives - Northern Antibiotics
Alternative Names: NAB 7061; NAB 737; NAB 739; NAB 741Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Northern Antibiotics
- Class Polymixins
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-negative-infections in Finland
- 28 Oct 2008 Preclinical pharmacokinetic and pharmacodynamic data presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America (ICAAC/IDSA-2008) ,,